| WASHINGTON (AP) -- What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?
HOUSTON (The New York Times News Service) -- Researchers have found that mothers' views about premarital sex don't affect their decisions on whether their pre-teen or teenage daughters should get the vaccine against the sexually transmitted virus that causes cervical cancer.
WASHINGTON (AP) -- Nearly three years into the Medicare drug benefit, federal officials have yet to ensure that private drug plans enacted programs to deter fraud and abuse, government investigators say.
WASHINGTON (AP) -- Federal drug safety regulators said Thursday they are investigating whether the cholesterol-lowering drug Vytorin can increase patients' risk of developing cancer.
WASHINGTON (AP) -- Many people in Medicare with diabetes, high blood pressure and other chronic conditions stop taking their medicine when faced with picking up the entire cost of their prescriptions, researchers say.
ATLANTA (AP) -- An expensive vaccine aimed at preventing cervical cancer makes sense for young teens when it comes to cost-effectiveness, but not for women in their 20s, contends a new report.
TRENTON, N.J. (AP) -- A 1999 Merck & Co. study of its since-withdrawn painkiller Vioxx, touted to participating doctors and patients as meant to show whether Vioxx caused fewer stomach problems than another drug, was primarily a stealth marketing strategy, researchers report.
WASHINGTON (AP) -- Federal regulators on Friday cleared the first treatment approved in the United States for Huntington's, a rare inherited disease that causes uncontrolled movements, deterioration of mental abilities and, ultimately, death.
WASHINGTON (AP) -- Federal regulators are working on a stronger label for a widely used diabetes drug marketed by Amylin Pharmaceuticals Inc. and Eli Lilly and Co. after deaths continue to be reported despite earlier government warnings.
WASHINGTON (AP) -- Top doctors at the helm of one of the nation's most influential medical journals are giving the Supreme Court some unsolicited legal advice about a major case.
BUENOS AIRES, Argentina (AP) -- Argentine authorities are exploring a possible link between the deaths of 14 children and an experimental vaccine they were taking in a clinical trial run by GlaxoSmithKline.
(The New York Times News Service) -- Parents who don't safeguard their medications are putting their teenagers at serious risk of addiction to prescription drugs, according to a national survey.
| News brought to you by: | | |  |  | | |
| 
